TMBIM1 and pancreatic neoplasm: Importantly, this enhancement was further pronounced when TMBIM1 knockdown was coupled with PD-1 blockade, underscoring the role of TMBIM1 in constraining T-cell-mediated immune responses in pancreatic cancer.